Shanghai Duoning Biotechnology Co., Ltd, a prominent player in China’s biopharmaceutical industry, has entered into a strategic partnership with BASF SE, a German chemical giant. This collaboration aims to enhance the promotion and commercialization of BASF’s medical materials and application products within mainland China. The products in focus include Kolliphor P188 BIO and Kolliphor P188 Cell Culture, both of which are specialized forms of poloxamer 188 used as shear protectants within cell cultures. The financial details of this partnership have not been disclosed.
Poloxamer 188 (P188) stands as a pivotal material in the production of biopharmaceuticals. The Kolliphor P188 BIO and Kolliphor P188 Cell Culture products are tailored for biotechnological applications. Their production processes incorporate specialized designs to optimize impurity control and manage molecular weight batch variations, resulting in superior performance in cell culture environments. Since its market launch in 2016, Kolliphor P188 BIO has been extensively utilized in the commercial manufacturing of a range of biopharmaceuticals, including antibody drugs, protein drugs, peptides, and cell and gene therapies worldwide.- Flcube.com
